Found 4767 matching trials
CardioNETPOL National Registry of Carcinoid Heart Disease
N/ACarcinoid tumors are neuroendocrine tumors (NETs), most commonly originatin...
Location
National Institute of Cardiology in Warsaw
Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability
NAThis randomized, double-blind, crossover human laboratory study compares th...
Location
Ohio State University Comprehensive Cancer Center
Survival of Patients With Primary Prophylactic ICD Indication
PHASE4The MADIT-II trial has shown that patients with severely reduced left ventr...
Location
A.ö. Krankenhaus der Stadt Linz
Serum Cortisol Levels in Patients With Anxiety and Depression With Symptomatic Oral Lichen Planus
NAOral lichen planus (OLP) is a T-cell mediated chronic immunological disease...
Location
Panineeya Institute of Dental Sciences
Risk Factors for Exertional Heat Illness
N/AThe arduous nature of military training and operations require personnel to...
Status
Active Not Recruiting
Location
Commando Training Centre Royal Marine
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
EARLY_PHASE1RATIONALE: Pioglitazone may slow the growth of tumor cells and may be an ef...
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
NAExisting trials for the patient with coronary heart disease evaluate the in...
Location
VA Tennessee Valley Healthcare System
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
PHASE2This phase II trial studies how well the addition of olaparib to the usual ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Boston Medical Center Ultrasound Decongestion Study in Heart Failure
NAThe purpose of this study is to analyze the utility of a novel five-point u...
Location
Boston Medical Center
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
PHASE2This phase II trial is studying how well medroxyprogesterone works in treat...
Location
Gynecologic Oncology Group